Metabolic activation pathways of cyclopenta-fused PAH and their relationship to genetic and carcinogenic activity
Nesnow, S.; Gold, A.; Mohapatra, N.; Sangaiah, R.; Bryant, B.J.; Rudo, K.; MacNair, P.; Ellis, S.
Progress in Clinical and Biological Research 209a: 515-522
1986
ISSN/ISBN: 0361-7742 PMID: 3749064 Document Number: 270989
Document emailed within 1 workday
Related Documents
Hein, D.W.; Doll, M.A.; Ferguson, R.J. 1995: Metabolic activation of carcinogenic arylamines by rapid acetylator, slow acetylator, and chimeric recombinant Syrian hamster NAT2 allozymes Proceedings of the Western Pharmacology Society 38: 59-62Motohashi, N.; Kurihara, T.; Sakagami, H.; Molnar, J. 1992: Relationship between resonance energy and carcinogenic activity of benz[c]acridines Anticancer Research 12(6b): 2105-2108
Mehta, R.D.; von Borstel, R.C. 1984: Genetic activity in yeast assays of reputed nonmutagenic, carcinogenic N-nitroso compounds and methapyrilene hydrochloride Iarc Scientific Publications 57: 721-729
Fahmy, O.G.; Fahmy, M.J. 1975: Genetic properties of N-alpha-acetoxymethyl-N-methylnitrosamine in relation to the metabolic activation of N,N-dimethylnitrosamine Cancer Research 35(12): 3780-3785
Neumann, H.G.; Metzler, M.; Brachmann, I.; Thomas, C. 1970: The relevance of chemico-biological interactions for the toxic and carcinogenic effects of aromatic amines. I. Carcinogenic activity of some 4-aminostilbene and 4-aminobibenzyl-derivatives Zeitschrift für Krebsforschung 74(2): 200-206
Jamieson, G.A. 1988: The activation of platelets by thrombin: a model for activation by high and moderate affinity receptor pathways Progress in Clinical and Biological Research 283: 137-158
Wood, A.W.; Levin, W.; Chang, R.L.; Huang, M.T.; Ryan, D.E.; Thomas, P.E.; Lehr, R.E.; Kumar, S.; Koreeda, M.; Akagi, H.; Ittah, Y.; Dansette, P.; Yagi, H.; Jerina, D.M.; Conney, A.H. 1980: Mutagenicity and tumor-initiating activity of cyclopenta(c,d)pyrene and structurally related compounds Cancer Research 40(3): 642-649
Zuo, H.-j.; Yao, C.-h.; Hu, Y.-s.; Kong, L.-z.; Yao, C.-H. 2010: Relationship between duration of low to moderate intensity physical activity and the prevalence of metabolic syndrome Zhonghua Yu Fang Yi Xue Za Zhi 44(10): 908-912
Ho, W.C.; Storrie, B.; Pepperkok, R.; Ansorge, W.; Karecla, P.; Kreis, T.E. 1990: Movement of interphase Golgi apparatus in fused mammalian cells and its relationship to cytoskeletal elements and rearrangement of nuclei European Journal of Cell Biology 52(2): 315-327
Kalinina, L.M.; Polukhina, G.N.; Lukasheva, L.I. 1977: Salmonella typhimurium as a test system for detecting the mutagenic activity of environmental pollutants. I. the mutagenic action of heavy metal salts in in vivo and in vitro systems without metabolic activation Genetika 13(6): 1089-1092
Dybing, E.; Von Bahr, C.; Aune, T.; Glaumann, H.; Levitt, D.S.; Thorgeirsson, S.S. 1979: In vitro metabolism and activation of carcinogenic aromatic amines by subcellular fractions of human liver Cancer Research 39(10): 4206-4211
Alcover, A.; Alberini, C.; Acuto, O.; Clayton, L.K.; Transy, C.; Spagnoli, G.C.; Moingeon, P.; Lopez, P.; Reinherz, E.L. 1988: Interdependence of CD3-Ti and CD2 activation pathways in human T lymphocytes EMBO Journal 7(7): 1973-1977
Durlach, J.; Bara, M.; Guiet-Bara, A.; Collery, P. 1986: Relationship between magnesium, cancer and carcinogenic or anticancer metals Anticancer Research 6(6): 1353-1361
Tatsumi, K.; Kitamura, S.; Amano, H.; Ueda, K. 1989: Comparative study on metabolic formation of N-arylformamides and N-arylacetamides from carcinogenic arylamines in mammalian species Cancer Research 49(8): 2059-2064
Suzuki, E.; Okada, M. 1981: Metabolic fate of N, N-dipropylnitrosamine and N, N-diamylnitrosamine in the rat, in relation to their lack of carcinogenic effect on the urinary bladder Gan 72(4): 552-561
Abignente, E.; De Caprariis, P.; Luraschi, E.; Marmo, E.; Berrino, L.; Lo Sasso, C. 1989: Research on heterocyclic compounds. XXV. Phenyl derivatives of fused imidazole systems: antiinflammatory activity Research Communications in Chemical Pathology and Pharmacology 65(1): 35-56
Sepulveda, H.; Cerwenka, A.; Morgan, T.; Dutton, R.W. 1999: CD28, IL-2-independent costimulatory pathways for CD8 T lymphocyte activation Journal of Immunology 163(3): 1133-1142
Goldstein, B.N.; Selivanov, V.A. 1990: Graph-theoretic approach to metabolic pathways Biomedica Biochimica Acta 49(8-9): 645-650
Veech, R.L.; Gitomer, W.L.; Casazza, J.P. 1987: Metabolic pathways leading to diol formation Progress in Clinical and Biological Research 241: 185-199
Uchida, K.; Hashimoto, S. 1984: Outline of metabolic pathways of bile acids Nihon Rinsho. Japanese Journal of Clinical Medicine 42(7): 1504-1508